Worsening renal function: What is a clinically meaningful change in creatinine during hospitalization with heart failure?
New Haven, Connecticut
Atlanta, Georgia
From the *Department of Medicine, Yale University School of Medicine, New Haven, Connecticut; †Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia; ‡Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, §Section of Chronic Disease Epidemiology, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut; ∥Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut (current affiliation: McMaster University, Hamilton, Ontario, Canada); and ¶Section of Health Policy and Administration, Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut
Received 26 July 2002; received in revised form 26 November 2002 and 27 November 2002
☆ Reprint requests to: Dr. Krumholz, Yale University School of Medicine, 333 Cedar Street, PO Box 208025, New Haven, CT 06520-8025.
☆☆ Dr. Watnick was a Robert Wood Johnson Clinical Scholar at Yale University during the time the work was conducted. She is currently affiliated with the Section of Nephrology, Oregon Health Sciences University and Portland VA Hospital.
PII: S1071-9164(02)25403-2
doi:10.1054/jcaf.2003.3
© 2003 Published by Elsevier Inc.
